Can alkaline phosphatase be elevated in Wilson disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alkaline Phosphatase in Wilson Disease: Characteristically Low, Not Elevated

Alkaline phosphatase is typically LOW or markedly subnormal in Wilson disease, particularly in acute liver failure presentations, not elevated. This is a critical diagnostic feature that distinguishes Wilson disease from other causes of liver failure.

Acute Liver Failure Presentation

In acute liver failure due to Wilson disease, alkaline phosphatase is characteristically markedly subnormal (typically <40 IU/L), accompanied by only modest transaminase elevations (typically <2000 IU/L). 1 This pattern is so distinctive that it serves as a key diagnostic clue.

Diagnostic Ratios

The low alkaline phosphatase pattern forms the basis of highly specific diagnostic ratios:

  • An alkaline phosphatase-to-total bilirubin ratio <2 strongly suggests Wilson disease in acute liver failure, with studies showing 100% sensitivity and specificity when this cutoff is applied 1, 2, 3
  • An alkaline phosphatase-to-total bilirubin ratio <4 yields 94% sensitivity and 96% specificity for diagnosing fulminant Wilson disease 2
  • The AST/ALT ratio is typically >2.2 (sensitivity 94%, specificity 86%) in fulminant Wilson disease 2

Clinical Context

Suspicion for acute Wilson disease should be particularly high in patients presenting with deep jaundice, Coombs-negative hemolytic anemia, low hemoglobin, low cholinesterase, only mildly increased transaminases, and LOW alkaline phosphatase. 1, 4 This constellation occurs because massive hepatocyte necrosis with copper-mediated inhibition of alkaline phosphatase activity characterizes the acute presentation 5.

Chronic Presentations

In chronic hepatitis and cirrhosis presentations of Wilson disease, alkaline phosphatase levels are typically normal or only mildly elevated, not markedly elevated like in primary cholestatic diseases 1, 4

Critical Pitfall to Avoid

Do not dismiss the possibility of Wilson disease in a young patient with acute liver failure simply because you expect elevated alkaline phosphatase in liver disease. The LOW alkaline phosphatase is the hallmark, and failure to recognize this pattern can delay life-saving liver transplantation 1, 5. The female-to-male ratio in acute Wilson disease is 4:1, and untreated acute liver failure from Wilson disease carries nearly 95% mortality 4.

Diagnostic Limitations

While the alkaline phosphatase-to-bilirubin ratio is highly useful, conventional Wilson disease testing (ceruloplasmin, serum copper) is less reliable in acute liver failure settings, with ceruloplasmin showing only 21-56% sensitivity depending on measurement method 2. The low alkaline phosphatase pattern combined with clinical features provides more rapid and accurate diagnosis 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Liver Disease Manifestations in Wilson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Considerations for Elevated PLP with Low Alkaline Phosphatase

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the most likely diagnosis in a 48‑year‑old female chronic alcoholic with alkaline phosphatase 461 U/L, AST 165 U/L, ALT 36 U/L, total bilirubin 7 mg/dL, ammonia 65 µmol/L, and NT‑proBNP 2512 pg/mL?
In a previously healthy 20‑year‑old woman with a 7‑day history of worsening jaundice, nausea, vomiting, right upper‑quadrant pain, markedly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), modestly increased alkaline phosphatase, and total bilirubin of 26 µmol/L, which laboratory test—bilirubin, albumin, prothrombin time, or ALT—provides the greatest prognostic value?
What is the diagnosis and treatment for a patient with elevated bilirubin, alkaline phosphatase, and AST?
What is the diagnosis and urgent management for a patient with alkaline phosphatase elevation, AST (aspartate aminotransferase) elevation, ALT (alanine aminotransferase) elevation, direct hyperbilirubinemia, hypoalbuminemia, and INR (international normalized ratio) elevation?
Does a 28‑year‑old asymptomatic man with persistent mild‑to‑moderate transaminitis (alanine aminotransferase/aspartate aminotransferase ≈100 U/L), modestly elevated alkaline phosphatase, normal bilirubin and coagulation, borderline low ceruloplasmin, elevated ferritin, dyslipidemia, and negative viral and autoimmune serologies need an immediate hepatology referral and additional testing (24‑hour urinary copper, serum copper, slit‑lamp examination for Kayser‑Fleischer rings, liver imaging), and what follow‑up schedule is appropriate?
Should physicians disclose the stage and severity (e.g., Stage III‑C) of a uterine cancer diagnosis to the patient at the time of diagnosis, or is withholding that information permissible?
A patient presents with acute right‑hand weakness, intermittent dysarthria, blood pressure 150/110 mm Hg, pulse 64 bpm, and SpO₂ 99% on room air. What is the most likely diagnosis and emergent management?
What is the recommended dose of Sporlac (Bacillus clausii) for an adult and for a child, and how should it be administered via a nasogastric tube?
What are the benign causes of hematospermia in otherwise healthy adult males?
What is the recommended first‑line antibiotic regimen for acute otitis media in children and adults, including dosing, duration, and alternatives for penicillin‑allergic patients?
What could be causing testicular atrophy in a 30-year-old man with noticeably smaller, pendulous testicles?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.